Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk
Byron J Hoogwerf, Krupa B Doshi, Dima DiabDepartment of Endocrinology, Diabetes and Metabolism, Cleveland Clinic Foundation, Cleveland, USAAbstract: Pramlintide is a synthetic version of the naturally occurring pancreatic peptide called amylin. Amylin and pramlintide have similar effects on lowering...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-04-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/pramlintide-the-synthetic-analogue-of-amylin-physiology-pathophysiolog-peer-reviewed-article-VHRM |